Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1454

1.

Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.

Engin E, Treit D, Dickson CT.

Neuroscience. 2009 Jun 30;161(2):359-69. doi: 10.1016/j.neuroscience.2009.03.038. Epub 2009 Mar 24. Erratum in: Neuroscience. 2009 Sep 15;162(4):1438-9.

PMID:
19321151
2.

Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence.

Engin E, Stellbrink J, Treit D, Dickson CT.

Neuroscience. 2008 Dec 2;157(3):666-76. doi: 10.1016/j.neuroscience.2008.09.037. Epub 2008 Oct 2.

PMID:
18940236
3.

Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?

Consoli D, Leggio GM, Mazzola C, Micale V, Drago F.

Eur J Pharmacol. 2007 Nov 14;573(1-3):139-47. Epub 2007 Jul 4.

PMID:
17669397
4.

Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test.

Wang X, Yang Y, Zhou X, Wu J, Li J, Jiang X, Qu Q, Ou C, Liu L, Zhou S.

Psychiatry Res. 2011 Jan 30;185(1-2):248-53. doi: 10.1016/j.psychres.2010.04.046. Epub 2010 May 23.

PMID:
20580983
5.

A critical test of the hippocampal theta model of anxiolytic drug action.

Yeung M, Treit D, Dickson CT.

Neuropharmacology. 2012 Jan;62(1):155-60. doi: 10.1016/j.neuropharm.2011.06.011. Epub 2011 Jun 23.

PMID:
21723303
6.

Antidepressant- and anxiolytic-like activity of magnesium in mice.

Poleszak E, Szewczyk B, Kedzierska E, Wlaź P, Pilc A, Nowak G.

Pharmacol Biochem Behav. 2004 May;78(1):7-12.

PMID:
15159129
7.
8.

Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp.

Karcz-Kubicha M, Jessa M, Nazar M, Plaznik A, Hartmann S, Parsons CG, Danysz W.

Neuropharmacology. 1997 Oct;36(10):1355-67.

PMID:
9423923
9.

Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.

Nakamura K, Kurasawa M.

Eur J Pharmacol. 2001 May 18;420(1):33-43.

PMID:
11412837
10.

Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.

Wesołowska A, Nikiforuk A, Stachowicz K, Tatarczyńska E.

Neuropharmacology. 2006 Sep;51(3):578-86. Epub 2006 Jul 7.

PMID:
16828124
12.

Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.

Wesołowska A, Nikiforuk A.

Neuropharmacology. 2007 Apr;52(5):1274-83. Epub 2007 Jan 20.

PMID:
17320917
13.

Anxiolytic and antidepressant-like effects of the hydroalcoholic extract from Aloysia polystachya in rats.

Mora S, Díaz-Véliz G, Millán R, Lungenstrass H, Quirós S, Coto-Morales T, Hellión-Ibarrola MC.

Pharmacol Biochem Behav. 2005 Oct;82(2):373-8. Epub 2005 Nov 8.

PMID:
16278011
14.

Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.

Rezvanfard M, Zarrindast MR, Bina P.

Pharmacology. 2009;84(6):356-66. doi: 10.1159/000256666. Epub 2009 Nov 11.

PMID:
19907194
15.
16.

NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.

Ghasemi M, Raza M, Dehpour AR.

J Psychopharmacol. 2010 Apr;24(4):585-94. doi: 10.1177/0269881109104845. Epub 2009 Apr 7.

PMID:
19351802
17.

Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents.

Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J.

J Pharmacol Sci. 2004 Jul;95(3):374-80.

18.

Effects of GABAB receptor ligands in animal tests of depression and anxiety.

Frankowska M, Filip M, Przegaliński E.

Pharmacol Rep. 2007 Nov-Dec;59(6):645-55.

19.

Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.

Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H.

Phytomedicine. 2008 Jan;15(1-2):2-15.

PMID:
18160026
20.

Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450.

Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, Vinken P, Ashton D, Langlois X, Steckler T.

Eur J Pharmacol. 2004 Feb 6;485(1-3):145-58.

PMID:
14757135

Supplemental Content

Support Center